Abstract
Gastric cancer (GC) is among the most treatment-refractory epithelial malignancies. Aberrant activation of Wnt/β-catenin-signaling has been implicated in a variety of human cancers, including gastric cancer. Here we report that the elevated expression of lymphoid enhancer binding factor 1 (Lef1) is associated with the TNM (tumor– node–metastasis) stage of gastric cancer. Subsequently, 2,4-diamino-quinazoline (2,4-DAQ), a selective inhibitor of Lef1, was identified to suppress the expression of Wnt/β-catenin target genes such as AXIN2, MYC and LGR5 and result in the suppression of gastric cancer cell growth through the apoptotic pathway. The 2,4-DAQ also exhibited an inhibitory effect on the migration/invasion of gastric cancer cells. Importantly, the treatment of human gastric tumor xenograft with 2,4-DAQ suppressed tumor growth in a nude mouse model. Furthermore, 2,4-DAQ appears effective on patient-derived organoids (PDOs). Transcriptome sequencing analysis also revealed that 2,4-DAQ are more effective on the gastric cancers that exhibit higher expression levels of Wnt-signaling pathway-related genes than their adjacent normal gastric tissues.
Highlights
Gastric cancer (GC) is one of the most common cancers and the 2nd cause of cancer-related deaths worldwide [1]
Through RNA sequencing and TruSeq targeted RNA Wnt-signaling panel analysis, we found that the lymphoid enhancer binding factor 1 (Lef1) gene was significantly upregulated in GC tissues and the expression level of Lef1 was positively correlated with the cancer stage
To avoid the interference of the low-quality RNAs that were prepared from the formalin-fixed samples, we utilized the preassembled gene panels (Wnt pathways panels) for targeted RNA sequencing to analyze the expression levels of Wnt signaling-related genes in GC
Summary
Gastric cancer (GC) is one of the most common cancers and the 2nd cause of cancer-related deaths worldwide [1]. Recent large-scale studies in molecular subtyping further defined GC into four subtypes, including Epstein–Barr virus-positive tumors, microsatellite unstable tumors, genomically stable tumors and tumors with chromosomal instability across genomic, transcriptomic and proteomic levels [9]. These classifications provide a roadmap for patient stratification, they have no impact on the choice of systemic treatment at present. Through RNA sequencing and TruSeq targeted RNA Wnt-signaling panel analysis, we found that the Lef gene was significantly upregulated in GC tissues and the expression level of Lef was positively correlated with the cancer stage.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have